Altering leukocyte recruitment following traumatic brain injury with ghrelin therapy

Journal of Trauma and Acute Care Surgery

Volumn 77, Issue 5, 2014, Pages 709-715

  Lee, Jisook ^a   Costantini, Todd W ^a   D'Mello, Ryan ^a   Eliceiri, Brian P ^a   Coimbra, Raul ^a   Bansal, Vishal ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Ghrelin; Leukocyte; Mice; Monocyte; Traumatic brain injury (TBI)

Indexed keywords

CD11B ANTIGEN; CD45 ANTIGEN; GHRELIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX LESION; CELL INFILTRATION; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; LEUKOCYTE; MALE; MICROGLIA; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TRAUMATIC BRAIN INJURY;

EID: 84925849423     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000000445     Document Type: Article

References (35)

1. Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006; 7: 41-53.
2. Lampron A, Elali A, Rivest S. Innate immunity in the CNS: redefining the relationship between the CNS and Its environment. Neuron. 2013; 78: 214-232.
3. Ransohoff RM, Brown MA. Innate immunity in the central nervous system. J Clin Invest. 2012; 122: 1164-1171.
4. Kwidzinski E, Mutlu LK, Kovac AD, Bunse J, Goldmann J, Mahlo J, Aktas O, Zipp F, Kamradt T, Nitsch R, et al. Self-tolerance in the immune privileged CNS: lessons from the entorhinal cortex lesion model. J Neural Transm Suppl. 2003: 29-49.
5. Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, Streit WJ, Salafranca MN, et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci U S A. 1998; 95: 10896-10901.
6. Coisne C, Lyck R, Engelhardt B. Live cell imaging techniques to study T cell trafficking across the blood-brain barrier in vitro and in vivo. Fluids Barriers CNS. 2013; 10: 7.
7. Takeshita Y, Ransohoff RM. Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models. Immunol Rev. 2012; 248: 228-239.
8. Das M, Mohapatra S, Mohapatra SS. New perspectives on central and peripheral immune responses to acute traumatic brain injury. J Neuroinflammation. 2012; 9: 236.
9. Loane DJ, Byrnes KR. Role ofmicroglia in neurotrauma. Neurotherapeutics. 2010; 7: 366-377.
10. Kumar A, Loane DJ. Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. Brain Behav Immun. 2012; 26: 1191-1201.
11. Ransohoff RM. Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity. 2009; 31: 711-721.
12. Rostene W, Kitabgi P, Parsadaniantz SM. Chemokines: a new class of neuromodulator? Nat Rev Neurosci. 2007; 8: 895-903.
13. Helmy A, Carpenter KL, Menon DK, Pickard JD, Hutchinson PJ. The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production. J Cereb Blood Flow Metab. 2010; 31: 658-670.
14. Utagawa A, Truettner JS, Dietrich WD, Bramlett HM. Systemic inflammation exacerbates behavioral and histopathological consequences of isolated traumatic brain injury in rats. Exp Neurol. 2008; 211: 283-291.
15. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007; 8: 57-69.
16. Smrcka M, Mrlian A, Karlsson-Valik J, Klabusay M. The effect of head injury upon the immune system. Bratisl Lek Listy. 2007; 108: 144-148.
17. Sanchez Mejia RO, Ona VO, Li M, Friedlander RM. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery. 2001; 48: 1393-1399; discussion 1399-1401.
18. Lu KT, Wang YW, Yang JT, Yang YL, Chen HI. Effect of interleukin-1 on traumatic brain injuryYinduced damage to hippocampal neurons. J Neurotrauma. 2005; 22: 885-895.
19. Lu KT, Wang YW, Wo YY, Yang YL. Extracellular signal-regulated kinaseYmediated IL-1Yinduced cortical neuron damage during traumatic brain injury. Neurosci Lett. 2005; 386: 40-45.
20. Tyor WR, Avgeropoulos N, Ohlandt G, Hogan EL. Treatment of spinal cord impact injury in the rat with transforming growth factor-beta. J Neurol Sci. 2002; 200: 33-41.
21. Dixit VD, Schaffer EM, Pyle RS, et al. Ghrelin inhibits leptin-and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest. 2004; 114: 57-66.
22. Dixit VD, Yang H, Cooper-Jenkins A, Giri BB, Patel K, Taub DD. Reduction of T cell-derived ghrelin enhances proinflammatory cytokine expression: implications for age-associated increases in inflammation. Blood. 2009; 113: 5202-5205.
23. Lopez NE, Gaston L, Lopez KR, Coimbra RC, Hageny A, Putnam J, Eliceiri B, Coimbra R, Bansal V. Early ghrelin treatment attenuates disruption of the blood brain barrier and apoptosis after traumatic brain injury through a UCP-2 mechanism. Brain Res. 2012; 1489: 140-148.
24. Lopez NE, Krzyzaniak MJ, Blow C, Putnam J, Ortiz-Pomales Y, Hageny AM, Eliceiri B, Coimbra R, Bansal V. Ghrelin prevents disruption of the blood-brain barrier after traumatic brain injury. J Neurotrauma. 2011; 29: 385-393.
25. Lopez NE, Lindsay G, Karina LR,Mary HA, Putnam J, Eliceiri B, Coimbra R, Bansal V. Ghrelin decreases motor deficits after traumatic brain injury. J Surg Res. 2014; 187: 230-236.
26. Feeney DM, Boyeson MG, Linn RT, Murray HM, Dail WG. Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res. 1981; 211: 67-77.
27. Xiong Y, Mahmood A, Chopp M. Animal models of traumatic brain injury. Nat Rev Neurosci. 2013; 14: 128-142.
28. Bansal V, Costantini T, Kroll L, Peterson C, LoomisW, Eliceiri B, Baird A, Wolf P, Coimbra R. Traumatic brain injury and intestinal dysfunction: uncovering the neuro-enteric axis. J Neurotrauma. 2009; 26: 1353-1359.
29. Kim JY, Kim N, Zheng Z, Lee JE, Yenari MA. The 70 kDa heat shock protein protects against experimental traumatic brain injury. Neurobiol Dis. 2013; 58: 289-295.
30. Cardona AE, Huang D, Sasse ME, Ransohoff RM. Isolation of murine microglial cells for RNA analysis or flow cytometry. Nat Protoc. 2006; 1: 1947-1951.
31. Chen Z, Jalabi W, Shpargel KB, Farabaugh KT, Dutta R, Yin X, Kidd GJ, Bergmann CC, Stohlman SA, Trapp BD. Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J Neurosci. 2012; 32: 11706-11715.
32. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev. 2011; 91: 461-553.
33. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996; 19: 312-318.
34. Qi L, Cui X, Dong W, Barrera R, Coppa GF, Wang P, Wu R. Ghrelin protects rats against traumatic brain injury and hemorrhagic shock through upregulation of UCP2. Ann Surg. 2014; 260: 169-178.
35. Molfino A, Formiconi A, Fanelli FR, Muscaritoli M. Ghrelin: from discovery to cancer cachexia therapy. Curr Opin Clin Nutr Metab Care. 2014.